Dosing of piperacillin/tazobactam in a morbidly obese patient

被引：17

作者：

Deman, Hanna ^{[1
]}

Verhaegen, Jan ^{[2
]}

Willems, Ludo ^{[1
]}

Spriet, Isabel ^{[1
]}

机构：

[1] Univ Hosp Leuven, Res Ctr Clin Pharm, Dept Pharm, B-3000 Louvain, Belgium

[2] Univ Hosp Leuven, Med Diagnost Sci Dept, B-3000 Louvain, Belgium

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2012年 / 67卷 / 03期

关键词：

-lactams; PK; PD; therapeutic drug monitoring; PHARMACOKINETICS;

D O I：

10.1093/jac/dkr503

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：782 / 783

页数：2

共 6 条

[1]

[Anonymous], 2006, PROD INF TOZ PIP TAZ

[2]

EUCAST, EUCAST CLIN BREAKP E

[3] Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection [J].

Li, CH ;

Kuti, JL ;

Nightingale, CH ;

Mansfield, DL ;

Dana, A ;

Nicolau, DP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (02) :388-395

[4] Serum Piperacillin/tazobactam pharmacokinetics in a morbidly obese individual [J].

Newman, Diane ;

Scheetz, Marc H. ;

Adeyemi, Oluwadamilola A. ;

Montevecchi, Mauro ;

Nicolau, David P. ;

Noskin, Gary A. ;

Postelnick, Michael J. .

ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) :1734-1739

[5] Therapeutic drug monitoring of antimicrobials [J].

Roberts, Jason A. ;

Norris, Ross ;

Paterson, David L. ;

Martin, Jennifer H. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) :27-36

[6] Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy [J].

Seyler, Lucie ;

Cotton, Frederic ;

Taccone, Fabio Silvio ;

De Backer, Daniel ;

Macours, Pascale ;

Vincent, Jean-Louis ;

Jacobs, Frederique .

CRITICAL CARE, 2011, 15 (03)

← 1 →